A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

ESA’s Jupiter Icy Moons Explorer (JUICE) that was launched in 2023 will take about 8 years to arrive at the jovian system after several gravity assists. Credit: Space.com | animation courtesy: ESA / ...

In 2019 I wrote about research suggesting anti-inflammatory medications might help some people with major depression. At the time, the idea that depression could have roots in the immune system felt ...

– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...

There are times when users are happy with the stock experience of your handset, but there are also Android users who might want to play around with custom themes, modifications, ROMs and so on. Don’t ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Danish drugmaker Novo Nordisk has licensed an experimental rare disease drug from biotechnology company Omeros that it sees becoming a differentiating treatment for an array of rare blood and kidney ...

Virus neutralization by early antisera usually requires or is enhanced by the presence of complement. The particular components of the complement system which are needed for neutralization of ...

CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...